Jenilkumar H. Patel

Jenilkumar H. Patel

Auto-generated profile, based on publicly available information

Jenilkumar H. Patel

Department of Otolaryngology Tulane University School of Medicine New Orleans Louisiana USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2024 in Health Open Research
Verified
Journal Article
Open access
JPJenilkumar Patel
Jenilkumar Patel
AKAngelle King
Angelle King
MMMahant Malempati
Mahant Malempati
MPMilee Patel
Milee Patel
Nootropics are substances that enhance cognition through various mechanisms. Nootropics include various substances, ranging from derivatives of neurotransmitters to naturally occurring plants. They are used therapeutically for certain psychological disorders including Alzheimer’s dementia and mild cognitive impairment. More recently, healthy individuals have been shown to consume nootropics to enhance mental processes above baseline levels. Nootropic modes of action vary, but the most supported mechanisms include increased acetylcholine levels in synapses, increased levels of monoamine oxidases, long-term potentiation through neural modulation of glutamate receptors, and decreased adenosine levels. However, numerous side effects can occur when taking nootropics, including insomnia, dependence, nausea, and anxiety. Nootropics also need to be considered when physicians prescribe them, as some individuals who request these drugs are perfectly healthy. In addition, the effects of nootropics are often misportrayed in popular media, leading individuals to think that these substances will give them a drastic increase in their cognitive ability.

14 March 2024 in Health Science Reports
Verified
Journal Article
Open access
PDF file
UDUdit Dave
Udit Dave
ELEmma G. Lewis
Emma G. Lewis
JPJenilkumar H. Patel
Jenilkumar H. Patel
NGNikhil Bhushan Godbole
Nikhil Bhushan Godbole
Background and Aims: The United States of America and Sweden both contain a public and private component to their healthcare systems. While both countries spend a similar amount per capita on public healthcare expenditures, the United States spends significantly more in the private healthcare sector. Sweden has a social democratic model of health care, and given its identity as a welfare state, private health insurance providers have a small and nuanced role.Methods: This paper was completed after searches were queried for “Sweden,” “United States,” and variants of the words “insurance,” “public,” “private,” “Medicare,” “Medicaid,” “public,” and “costs.” A preliminary search in May 2022, yielded 78 articles, of which 45 were ultimately considered relevant for this review. Inclusion criteria consisted of English language articles, topic relevance, and verification of MEDLINE‐indexed journals. These searches were performed in PubMed, Google Scholar, Embase, and Cochrane. Summary findings of these searches are compiled in this review.Results: Sweden guarantees low‐cost appropriate care to all citizens with equitable access; however, drawbacks of its system include high financial burden, lack of primary care infrastructure, as well as geographical and socioeconomic inequities. On the other hand, the United States' healthcare system is built around the private sector with public health insurance reserved only for the most vulnerable patient populations.Conclusion: Our goal is to provide an overview, compare the role of private health insurance in both countries, and highlight policies that have had beneficial effects in each nation. Possible solutions to the drawbacks of each nation's health insurance policies could be addressed by additional support to Sweden's vulnerable population by developing a program similar to the US' Medicare Advantage program. Conversely, the United States may benefit from increasing access to public health insurance, especially in instances where families face unemployment.

6 October 2022 in Anatomy & Cell Biology
Verified
Journal Article
Open access
PDF file
JPJenilkumar Patel
Jenilkumar Patel
GDGraham Dupont
Graham Dupont
JKJoho Katsuta
Joho Katsuta
JIJoe Iwanaga
Joe Iwanaga
ŁOŁukasz Olewnik
Łukasz Olewnik
STShane Tubbs
Shane Tubbs
Jenilkumar Patel, Graham Dupont, Joho Katsuta, Joe Iwanaga, Łukasz Olewnik, R. Shane Tubbs. Anat Cell Biol -0001;0:. https://doi.org/10.5115/acb.22.009

23 March 2026 in The Laryngoscope
Verified
Journal Article
Open access
PDF file
JPJenilkumar H. Patel
Jenilkumar H. Patel
DGDuncan G. J. Green
Duncan G. J. Green
MMManal S. Malik
Manal S. Malik
SWSteven X. Wang
Steven X. Wang
Edward McCoulEdward McCoul
Edward McCoul
Objective: Eustachian tube dysfunction (ETD) is traditionally classified as either patulous or obstructive. Recent evidence suggests that obstructive ETD may comprise a broad array of clinical presentations. This study aimed to define subtypes of obstructive ETD according to common clinical features. Methods: This cross‐sectional study included adults diagnosed with ETD at a single academic medical center between October 2014 and June 2022. Clinical data was recorded, including patient‐reported ETDQ‐7 score, nasal endoscopy findings, tympanometry findings, medical comorbidities, timing of symptoms, symptom laterality and duration of ear fullness. Principle component analysis (PCA) was used to distinguish the most important clinical features and hierarchical cluster analysis was used to delineate symptom cluster groups. Results: Among 490 obstructive ETD patients, seven clinical characteristics were found to be the most important: duration, severity, laterality, constancy, sinusitis symptoms, history of pressure equalization tube, and comorbid reflux disease. Five phenotypic clusters were described by the clinical data, which were predictive of relative risk of comorbidity of sinusitis and GERD, as well as abnormality on endoscopy and tympanometry. Patients with bilateral symptoms had longer mean symptom duration than patients with unilateral symptoms (8.5 vs. 6.1 months; p < 0.001) and patients with sinusitis symptoms were more likely to have bilateral symptoms compared to those without (76.6% vs. 59.1%; OR = 0.442 [95% CI: 0.330, 0.651]; p < 0.001). Conclusion: Our group has identified five data‐driven symptom cluster groups that may be translated into clinical practice. Level of Evidence: 3

29 August 2022 in Journal of Orthopaedic Reports
Verified
Journal Article
Open access
UDUdit Dave
Udit Dave
ELEmma G. Lewis
Emma G. Lewis
JPJenilkumar H. Patel
Jenilkumar H. Patel

3 October 2026 in The American Journal of Cardiology
Verified
Journal Article
Closed access
JPJenilkumar H. Patel
Jenilkumar H. Patel
MCMarjorie Flores Chang
Marjorie Flores Chang
SZSamer Zakhour
Samer Zakhour
SSSudesh Srivastav
Sudesh Srivastav
AIAnand Irimpen
Anand Irimpen